Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder (THC-BD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03206463
Recruitment Status : Active, not recruiting
First Posted : July 2, 2017
Last Update Posted : July 10, 2019
Sponsor:
Information provided by (Responsible Party):
Mohini Ranganathan, Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : July 2019